Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy
about
Chronic impact of traumatic brain injury on outcome and quality of life: a narrative reviewNMR Meets Tau: Insights into Its Function and PathologyNew Features about Tau Function and DysfunctionTraumatic Axonal Injury: Mechanisms and Translational OpportunitiesFunction and regulation of tau conformations in the development and treatment of traumatic brain injury and neurodegenerationTowards Personalized Intervention for Alzheimer's DiseaseChronic Repetitive Mild Traumatic Brain Injury Results in Reduced Cerebral Blood Flow, Axonal Injury, Gliosis, and Increased T-Tau and Tau OligomersAffinity of Tau antibodies for solubilized pathological Tau species but not their immunogen or insoluble Tau aggregates predicts in vivo and ex vivo efficacy.Perivascular AQP4 dysregulation in the hippocampal CA1 area after traumatic brain injury is alleviated by adenosine A2A receptor inactivation.Considerations for Experimental Animal Models of Concussion, Traumatic Brain Injury, and Chronic Traumatic Encephalopathy-These Matters Matter.Mapping the Connectome Following Traumatic Brain Injury.Stabilization of Microtubule-Unbound Tau via Tau Phosphorylation at Ser262/356 by Par-1/MARK Contributes to Augmentation of AD-Related Phosphorylation and Aβ42-Induced Tau Toxicity.Modeling Chronic Traumatic Encephalopathy: The Way Forward for Future Discovery.Preliminary Study of Plasma Exosomal Tau as a Potential Biomarker for Chronic Traumatic Encephalopathy.Microglial neuroinflammation contributes to tau accumulation in chronic traumatic encephalopathy.The Expression of NP847 and Sox2 after TBI and Its Influence on NSCs.Neuroinflammation in animal models of traumatic brain injury.Cytosolic Fc receptor TRIM21 inhibits seeded tau aggregation.Sports-related concussions - media, science and policy.MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways.Mild traumatic brain injury-induced hippocampal gene expressions: The identification of target cellular processes for drug development.A mouse Model of Focal Vascular Injury Induces Astrocyte Reactivity, Tau Oligomers, and Aberrant Behavior.Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.Neurodegenerative disease in 2015: Targeting tauopathies for therapeutic translationMemantine improves outcomes after repetitive traumatic brain injury.Microstructural and microglial changes after repetitive mild traumatic brain injury in mice.The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target.Environmental Enrichment Mitigates Deficits after Repetitive Mild Traumatic Brain Injury.The role of Pin1 in the development and treatment of cancer.Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy.The Role of Microglia in the Etiology and Evolution of Chronic Traumatic Encephalopathy.Neighboring phosphoSer-Pro motifs in the undefined domain of IRAK1 impart bivalent advantage for Pin1 binding.A Brief Overview of Tauopathy: Causes, Consequences, and Therapeutic Strategies.Prion-like Spreading in Tauopathies.Noncontact Rotational Head Injury Produces Transient Cognitive Deficits but Lasting Neuropathological Changes.Internalization of tau antibody and pathological tau protein detected with a flow cytometry multiplexing approachSignature of an aggregation-prone conformation of tau.Cis P-tau is induced in clinical and preclinical brain injury and contributes to post-injury sequelae.The Biological Basis of Chronic Traumatic Encephalopathy following Blast Injury: A Literature Review.ReMAPping the microtubule landscape: How phosphorylation dictates the activities of microtubule-associated proteins.
P2860
Q26744281-FB305DE9-64CA-454C-9FF7-562809EE8846Q26747418-4F88B9EC-E363-46DC-A180-94C331853713Q26750922-FBC6A4DD-9ACE-4BC2-82A7-3C8210C86FCCQ26753059-4086D58B-89CF-4E6B-BA6D-88F622BD6EEBQ28080073-12D51B87-6EE5-488C-A8CF-827442D83772Q28080098-F5B6A3B0-F9D9-4E19-805E-1E29C9EB5699Q28397264-89B3A3D7-E65A-487E-8FEA-A2449F1799C8Q30805841-D5C0E727-2FE4-434D-BE8F-649CFF1B717CQ33714909-CB9D7C39-150E-4CD2-83DD-7B0AA7CD9FCAQ33747407-89EB707C-49D8-4842-914A-40C842E858EEQ35972236-B6C8C619-DBEC-4AB1-ADF3-B8D0746CC7C9Q35972860-204DE417-FB4A-4554-A821-D69D200A6C7CQ36206627-4174F581-5284-425A-929A-2C8068D6A286Q36803316-EFE6A0D3-98AF-4291-BA06-76E66FA8358EQ37374408-B5B2E50F-494F-4A18-BC11-A8D8A84B1D04Q37525476-85AF4076-8D4D-4822-84CA-7632DCC31DE3Q37546147-0C945728-E612-406F-88F5-3AFB64807F46Q37598940-75B1D81F-6382-4A88-BCF0-3F88C3D3D4AEQ37676914-10B7F17C-EFAE-4694-8CC9-BD1BD9D3BBF2Q37739814-CC5CF18E-3B56-4A67-95C9-85920077123BQ38451090-0410EA33-582F-47EF-B424-6B8CDFE8FCC1Q38652516-8CDA85CD-6CBA-414C-9425-AB889A1366AAQ38666247-F282D843-5F0F-437A-A195-D11462B11CC1Q38705770-D8BF33DA-896F-4738-817A-E50C4B4F85E4Q38835597-C0E27C75-4400-4EC5-B102-5E21F1DE9F0FQ38838386-3F1433F5-265C-4E0D-97E4-879E9520830AQ38852028-17C9A01E-3DBB-484F-92A0-4AD5DE66A8A0Q38855306-B536C0DA-DA6A-4289-B6CA-24E566E0B5FDQ38939954-8707BC47-D802-4D24-B89C-4FDC43636F8FQ38998886-C0117FE3-B909-4CE7-A7A8-5DB5C9D01C86Q39149587-22CC3EAB-2E2F-474A-AD94-3D754CCF252AQ39240086-227ACA7A-F110-42E5-BF09-765715771050Q39270980-5DECD0BA-0929-4573-8152-9EBF06A80AA3Q39307688-3EBF4C73-6F8F-482A-B4E0-75EABC8AFE58Q40134768-3534620D-8D60-4EFE-B75D-BD7E51C212B9Q41629521-487AED6C-4190-44F9-8F69-48EAE550409DQ41900247-EB25BE0F-C9F1-407E-A1E7-DC101BBF08ECQ42379648-3E557C25-45C1-4091-98F1-2E8F056A85E3Q45068024-F445AD8E-54B0-4C20-B02C-778538A704EAQ46180253-83E594D9-2AC4-4427-9E32-91F5F579BEEE
P2860
Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Antibody against early driver ...... cks brain injury and tauopathy
@ast
Antibody against early driver ...... cks brain injury and tauopathy
@en
Antibody against early driver ...... cks brain injury and tauopathy
@nl
type
label
Antibody against early driver ...... cks brain injury and tauopathy
@ast
Antibody against early driver ...... cks brain injury and tauopathy
@en
Antibody against early driver ...... cks brain injury and tauopathy
@nl
prefLabel
Antibody against early driver ...... cks brain injury and tauopathy
@ast
Antibody against early driver ...... cks brain injury and tauopathy
@en
Antibody against early driver ...... cks brain injury and tauopathy
@nl
P2093
P2860
P3181
P356
P1433
P1476
Antibody against early driver ...... cks brain injury and tauopathy
@en
P2093
Akihide Ryo
Alexander Rotenberg
Ann C McKee
Asami Kondo
Chun-Hau Chen
Jane A Driver
Jianhua Qiu
Koorosh Shahpasand
Kun Ping Lu
Lee E Goldstein
P2860
P2888
P304
P3181
P356
10.1038/NATURE14658
P407
P577
2015-07-15T00:00:00Z
P6179
1053696664